A detailed history of Entry Point Capital, LLC transactions in Iradimed Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,210 shares of IRMD stock, worth $236,602. This represents 0.27% of its overall portfolio holdings.

Number of Shares
4,210
Previous 3,399 23.86%
Holding current value
$236,602
Previous $150 Million 23.72%
% of portfolio
0.27%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.36 - $44.7 $32,731 - $36,251
811 Added 23.86%
4,210 $185 Million
Q1 2024

May 14, 2024

BUY
$41.17 - $47.29 $139,936 - $160,738
3,399 New
3,399 $150 Million

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $706M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.